MetLife (MET) stock

Financials · Life & Health Insurance

$98.82
-$4.75 -4.59%
Close

MetLife (MET) is a Life & Health Insurance company in the Financials sector, headquartered in New York City, New York. As of October 23, 2026, MET closed at $98.82, a market capitalization of $62.80 billion, the 197th largest company in the S&P 500. Over the last twelve months it generated $79.40 billion in revenue (+10% year over year) and $15.56 billion in free cash flow. The stock trades at 18.9x trailing earnings and 8.9x forward earnings.

  • 1-year total return: +30.0% (dividends reinvested)
  • 5-year return: +11.8% a year
  • 52-week range: $67.33 – $103.65
  • Gross margin 24.0%, operating margin 5.5%
  • Dividend yield: 2.40%, 12 straight years of increases
  • FI Handbook report card: B- across 10 metrics
  • 33rd largest of 76 Financials stocks in the S&P 500

MET price chart

1Y price change: +26.4% (price only; total returns below include dividends)

$80.00
$100.00
Nov2026MarMayJulSep
MET total returns
Total return1MYTD1Y3Y5Y10YMAX
MET+1.7%+27.8%+30.0%+22.7%+11.8%+12.8%+10.2%

Dividends reinvested. 3Y and longer are annualized; MAX is annualized since 2000.

MET key statistics

Market cap
$62.8B
#197 in S&P 500
P/E (TTM)
18.9x
Forward P/E
8.9x
EPS (TTM)
$5.22
Revenue (TTM)
$79.4B
+11%
Free cash flow
$15.6B
Gross margin
24.0%
Operating margin
5.5%
Return on equity
13.1%
Dividend yield
2.40%
52-week range
$67.33 – $103.65
Beta
0.78
Price / sales
0.8x
EV / EBITDA
14.3x
Debt / equity
1.80x
Employees
46,000

MET report card

B-

Ten fundamentals graded A to F against fixed thresholds. Not a buy or sell rating.

  • Revenue growth10.5%B
  • Gross margin24.0%D
  • Operating margin5.5%D
  • FCF margin19.6%B
  • Return on equity13.1%C
  • Net debt / EBITDA3.8xF
  • Forward P/E8.9xA
  • PEG ratio0.5xA
  • Shareholder yield7.0%A
  • Share count change / yr-5.9%A

MetLife financials

Revenue went from $60.8B in fiscal 2016 to $2.4B in fiscal 2025, shrinking 30.1% a year.

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
MetLife annual financial results
Fiscal year2016201720182019202020212022202320242025
Revenue$60.8B$62.3B$1.3B$1.3B$1.4B$2.1B$2.1B$2.2B$2.2B$2.4B
Operating income——————$6.0B$5.7B$6.0B$6.1B
Net income$850.0M$4.0B$5.1B$5.9B$5.4B$6.9B$5.3B$1.6B$4.4B$3.4B
EPS (diluted)$0.67$3.62$4.91$6.06$5.68$7.65$6.30$1.81$5.94$4.71
Buybacks$372.0M$2.9B$4.0B$2.3B$1.2B$4.3B$3.3B$3.1B$3.2B$2.9B
Dividends paid$1.7B$1.7B$1.7B$1.6B$1.7B$1.6B$1.6B$1.6B$1.5B$1.5B
Diluted shares1.1B1.1B1.0B944.4M913.2M869.4M808.9M762.3M711.1M673.3M

Source: SEC filings (10-K XBRL). EPS and share counts are split-adjusted.

PRO
15 years of financials, quarterly data and CSV export

Coming with FI Handbook Pro.

See Pro

What's priced into MET?

A reverse DCF asks what growth the current price requires. With an enterprise value of $85.8B and $15.6B of trailing free cash flow, MetLife needs to grow free cash flow about -19.9% a year for ten years (fading to 3.0% terminal growth) to earn a 10% annual return.

P/E ratio history

Current 21.0x vs. median 10.5x (10th–90th percentile 6.3x–43.3x).

0x
25x
50x
75x
20122014201620182020202220242026

A model, not a forecast or advice. Small changes in assumptions move the answer a lot.

MET dividend

Dividend yield
2.40%
Annual dividend
$2.37
Years of increases
12
5-yr dividend growth
4.3%
per year
Payout ratio
44%
Payments per year
4
201120122013201420152016201720182019202020212022202320242025

Regular dividends per share by calendar year; special dividends excluded. Current year omitted until complete.

MET earnings

Next report: November 4, 2026. MetLife has beaten EPS estimates 4 quarters in a row. Last quarter's revenue was $18.9B (+10% year over year).

Report dateEPS estimateEPS actualSurprise
Aug 5, 2026$2.29$2.43+6.2%
May 6, 2026$2.27$2.42+6.7%
Feb 4, 2026$2.34$2.49+6.3%
Nov 5, 2025$2.32$2.37+2.2%
Aug 6, 2025$2.16$2.02-6.7%
Apr 30, 2025$2.01$1.96-2.5%
Feb 5, 2025$2.09$2.09-0.2%
Oct 30, 2024$2.18$1.95-10.7%

Stocks like MET

NameToday1YMkt capP/E
AFL AFLAC-2.24%+14%$60.4B13.0xCompare
PRU Prudential Financial-2.69%+19%$39.7B10.4xCompare
PFG Principal Financial-1.40%+41%$23.2B15.5xCompare
GL Globe Life-8.09%+15%$11.9B10.4xCompare
BRK-B Berkshire Hathaway-0.87%+11%$1.2T13.6xCompare
JPM JP Morgan Chase-1.47%+15%$880.5B13.9xCompare
V Visa-1.55%+19%$765.8B34.7xCompare
MA Mastercard-1.52%+9%$546.3B34.3xCompare
Make a shareable MET chartFree infographics for X, Reddit and your blog.

MET news

MET stock FAQ

What is MET's market cap?

MetLife's market capitalization is $62.80 billion as of October 23, 2026, ranking 197th in the S&P 500.

What is MET's P/E ratio?

MET trades at a trailing price-to-earnings ratio of 18.9x and a forward P/E of 8.9x. Its median P/E over the period we track is 10.5x.

Does MET pay a dividend?

Yes. MetLife pays $2.37 per share a year, a 2.40% yield. It has raised its dividend 12 years in a row. Dividends grew 4.3% a year over the last five years.

How much has MET stock returned?

Including reinvested dividends, MET returned +30.0% over one year, +11.8% a year over five years, +12.8% a year over ten years through October 23, 2026.

Is MET stock overvalued?

At today's price, a reverse discounted cash flow model (10% discount rate, 3% terminal growth) implies MetLife must grow free cash flow about -20% a year for the next decade. Whether that is achievable decides if the stock is cheap or expensive. This is a model, not advice.

When does MET report earnings?

MetLife is expected to report earnings on November 4, 2026. It has beaten EPS estimates 4 quarters in a row.

How many employees does MetLife have?

MetLife has about 46,000 full-time employees, or $1.7 million of revenue per employee.

Sources: SEC EDGAR filings, Yahoo Finance market data (delayed), FI Handbook calculations. Last close October 23, 2026. Methodology